Trends in Use of Obesity Medications and Metabolic and Bariatric Surgery Among All of Us Participants From 2003 to 2023.

Key Points

• The aim is to examine trends in obesity medication and metabolic surgery usage over two decades.
• Analysis of participant data from 2003 to 2023
• Comparison of obesity medication and metabolic surgery usage rates
• Assessment of the impact of semaglutide approval on medication usage
• Increased use of obesity medications (AOM) is noted.
• Metabolic bariatric surgery (MBS) usage remained stable during the same period.
• Semaglutide approval correlated with a rise in AOM use but did not affect MBS usage.